Amplicon melting analysis with saturation dyes

1. A method of PCR analysis comprising the steps of:

mixing a dsDNA binding dye having a percent saturation of at least 90% with a sample comprising a selected target nucleic acid and primers configured for amplifying the selected target nucleic acid,

amplifying the target nucleic acid in the presence of the dsDNA binding dye, and

monitoring fluorescence of the dsDNA binding dye, wherein the monitoring step comprises

melting the amplified target nucleic acid to generate a melting curve,

repeating the mixing, amplifying, and generating a melting curve steps with at least one additional target nucleic acid, and comparing the melting curves,

wherein the melting curve for the selected target nucleic acid is selected as the standard and is plotted as stranded across melting temperatures and the melting curve for each additional target nucleic acid is plotted as a difference from the stranded across the melting curves.

2. The method of claim 1 wherein the target nucleic acid comprises a single nucleotide polymorphism, and the identifying step comprises identifying resultant heteroduplexes and homoduplexes.

3. The method of claim 1 wherein the method comprises mutation scanning by comparing the melting curves.

4. The method of claim 1 further comprising the step of temperature shifting the melting curves by superimposing a portion of each curve.

5. The method of claim 4 further comprising the step of plotting the fluorescence difference between the temperature shifted curves, wherein the melting curve for the target nucleic acid is selected as the standard and is plotted as standard across melting temperatures and the melting curve for each additional target nucleic acid is plotted as a difference from the standard across the melting temperatures.

6. The method of claim 1 wherein the dye is selected from the group consisting of PO-PRO™−1, JO-PRO™−1, SYTO®45, POPO™−3, SYTO®12, TOTO™−3, SYTOX™ Blue, YOYO®−3, SYTO®43, SYTO®11, G5, H5, D6, E6, P6, R6, Y6, Z6, and D8.

7. A method of PCR analysis comprising the steps of:

mixing a dsDNA binding dye having a percent saturation of at least 50% with a sample comprising a target nucleic acid and primers configured for amplifying the target nucleic acid,

amplifying the target nucleic acid in the presence of the dsDNA binding dye, and

monitoring fluorescence of the dsDNA binding dye, wherein the monitoring step comprises melting the amplified target nucleic acid to generate a melting curve, and

identifying the genotype using a shape of the melting curve, and wherein the dsDNA binding dye is a compound having the formula:

wherein

the moiety  represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;

X is oxygen, sulfur, selenium, tellurium or a moiety selected from C(CH 3 ) 2 and NR 1 , where R 1 is hydrogen or C 1-6 alkyl;

R 2 is selected from the group consisting of C 1-6 alkyl, C 3-8 cycloalkyl, aryl, aryl(C 1-2 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, alkylsulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties;

t=0 or 1;

Z is a charge selected from 0 or 1;

R 3 is selected from the group consisting of hydrogen, C 1-6 alkyl, and —C(O)Ph;

R 9 and R 10 are each independently selected from the group consisting of hydrogen and C 1-6 alkyl;

n=0, 1, or 2;

 indicates a single bond that is in a tautomeric relationship with an adjacent double bond, and

Q is an heterocycle selected from the group of structures consisting of:

wherein R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, alkylthio, and dialkylamino, each of which may be optionally substituted; an acyclic heteroatom-containing moiety or a cyclic heteroatom-containing moiety; a BRIDGE-DYE; and a reactive group; each of which optionally includes a quaternary ammonium moiety.

8. The method of claim 7 wherein the moiety  represents an optionally-substituted fused monocyclic or polycyclic aromatic ring selected from the group consisting of optionally substituted benzo, optionally substituted pyridino, and optionally substituted naphtho; and X is oxygen or sulfur.

9. The method of claim 7 wherein the moiety  represents a benzo or a naphtho having a substituent selected from the group consisting of halo, alkyl, amino, monoalkylamino, dialkylamino, alkylsulfonyl, haloalkylsulfonyl, and optionally substituted phenylsulfonyl.

10. The method of claim 7 wherein R 2 is selected from the group consisting of C 1-6 alkyl, C 3-8 cycloalkyl, aryl, aryl(C 1-2 alkyl), aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, trialkylammoniumalkyl, alkylsulfonate, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties.

11. The method of claim 7 wherein Q is the heterocycle:

12. The method of claim 7 wherein R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from the group consisting of hydrogen, halogen, thiol, alkylthio, alkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, trialkylammmoniumalkyl, piperidino, piperazino, 4-methylpiperazinium-1-yl, and aryl.

13. The method of claim 7 wherein t is 1, n=0, and at least one of R 4 , R 5 , R 6 , R 7 , and R 8 is selected from the group consisting of halogen, thiol, alkylthio, C 2-6 alkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, trialkylammmoniumalkyl, piperidino, piperazino, 4-methylpiperazinium-1-yl, and aryl.

14. The method d of claim 13 wherein R 5 is selected from the group consisting of halogen, thiol, C 2-6 alkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, trialkylammmoniumalkyl, piperidino, piperazino, 4-methylpiperazinium-1-yl, and aryl.

15. The method of claim 13 wherein R 3 , R 9 , and R 10 are each hydrogen; and R 2 is selected from the group consisting of C 1-6 alkyl, aryl, aryl(C 1-2 alkyl), aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, trialkylammoniumalkyl, alkylsulfonate, and alkylenesulfonate.

16. A method of PCR analysis comprising the steps of:

providing a mixture of a dsDNA binding dye having at least 90% saturation, a target nucleic acid, and primers configured for amplifying the target nucleic acid,

amplifying the target nucleic acid in the presence of the dsDNA binding dye,

monitoring fluorescence of the dsDNA binding dye,

generating a melting curve for the target nucleic acid,

normalizing magnitude differences of the melting curve,

repeating the providing, amplifying, generating and normalizing steps with at least one additional target nucleic acid,

comparing the magnitude difference normalized melting curves, and plotting the fluorescence difference between the magnitude difference normalized curves, wherein the melting curve of one selected target nucleic acid is selected as the standard and is plotted as standard across melting temperatures and the melting curve for each additional target nucleic acid is plotted as a difference from the standard across the melting temperatures.

17. A method of PCR analysis comprising the steps of:

providing a mixture of a dsDNA binding dye having at least 90% saturation, a target nucleic acid, and primers configured for amplifying the target nucleic acid,

amplifying the target nucleic acid in the presence of the dsDNA binding dye,

monitoring fluorescence of the dsDNA binding dye,

generating a melting curve for the target nucleic acid,

normalizing magnitude differences of the melting curve,

repeating the providing, amplifying, generating and normalizing steps with at least one additional target nucleic acid,

comparing the magnitude difference normalized melting curves, and plotting the fluorescence difference between the magnitude difference normalized curves, wherein the melting curve of one selected target nucleic acid is selected as the standard and is plotted as standard across melting temperatures and the melting curve for each additional target nucleic acid is plotted as a difference from the standard across the melting temperatures wherein the standard is plotted as zero across all melting temperatures.

18. The method of claim 16 further comprising the step of temperature shifting melting curves by superimposing a portion of each curve and plotting the fluorescence difference between the temperature shifted curves, wherein the melting curve for the target nucleic acid is selected as the standard and is plotted as standard across melting temperatures and the melting curve for each additional target nucleic acid is plotted as a difference from the standard across the melting temperatures.